课题基金 / 基金详情

Identifying The Lethal Ancestral Clones of Metastatic Disease in Primary Prostate Cancer

Identifying The Lethal Ancestral Clones of Metastatic Disease in Primary Prostate Cancer
鉴定原发性前列腺癌转移性疾病的致命祖先克隆
批准号:
386497
负责人:
Warner Evan
金额:
$1.27万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-12-01 至 2018-12-01

项目摘要

项目成果

Warner Evan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Most primary prostate cancer responds well to surgery and localized intervention, but 10% of men relapse with a more aggressive form of the disease known as castration-resistant prostate cancer (CRPC). Currently, there are no approved methods for predicti
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Frequency and etiology of ctDNA-positive metastatic prostate cancer with BRCA2, ATM, or CDK12 mutations
  • 批准号:
    412180
  • 项目类别:
  • 资助金额:
    $0.11万
  • 财政年份:
    2019
  • 负责人:
    Warner Evan
  • 依托单位:
Frequency and etiology of ctDNA-positive metastatic prostate cancer with BRCA2, ATM, or CDK12 mutations
  • 批准号:
    417226
  • 项目类别:
    Studentship Programs
  • 资助金额:
    $7.65万
  • 财政年份:
    2019
  • 负责人:
    Warner Evan
  • 依托单位:
Identifying apparently curable prostate cancer with occult lethal trajectory
Identifying the lethal ancestral clones of metastatic disease in primary prostate cancer
  • 批准号:
    391730
  • 项目类别:
  • 资助金额:
    $0.08万
  • 财政年份:
    2018
  • 负责人:
    Warner Evan
  • 依托单位:
海外基金